期刊
SCIENCE IN CHINA SERIES C-LIFE SCIENCES
卷 52, 期 7, 页码 622-636出版社
SCIENCE PRESS
DOI: 10.1007/s11427-009-0092-6
关键词
induced pluripotent stem (iPS) cells; somatic cell reprogramming; pluripotency
类别
资金
- National Key Basic Research and Development Program of China [2009CB941000]
- Ministry of Science and Technology of China, and the transgenic program [2009ZX08006-010B]
- National Natural Science Foundation of China [90919009]
- Ministry of Agriculture of China [2009ZX08006-011B]
Induced pluripotent stem (iPS) cells are derived from somatic cells by ectopic expression of few transcription factors. Like embryonic stem (ES) cells, iPS cells are able to self-renew indefinitely and to differentiate into all types of cells in the body. iPS cells hold great promise for regenerative medicine, because iPS cells circumvent not only immunological rejection but also ethical issues. Since the first report on the derivation of iPS cells in 2006, many laboratories all over the world started research on iPS cells and have made significant progress. This paper reviews recent progress in iPS cell research, including the methods to generate iPS cells, the molecular mechanism of reprogramming in the formation of iPS cells, and the potential applications of iPS cells in cell replacement therapy. Current problems that need to be addressed and the prospects for iPS research are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据